We use our own and third-party cookies to optimize your experience on this site, including to maintain user sessions. Without these cookies our site will not function well. If you continue browsing our site we take that to mean that you understand and accept how we use the cookies. If you wish to decline our cookies we will redirect you to Google.
Already have an account? Sign in.

 Remember Me | Forgot Your Password?

U.S. PTO Grants Patent For Glanbia's Whey-Derived Ingredient

September 9, 2010: 06:58 AM EST

The U.S. Patent and Trademark Office has granted a patent to Glanbia Nutritionals for a whey-derived ingredient that includes proprietary whey peptides. According to the company, Prolibra is “clinically proven to significantly decrease fat mass” and maintain lean body mass when combined with a low-calorie diet. The product also helps decrease the glycemic response that occurs after eating. The company cites the results of three clinical trials as evidence for its health claims. In one, total body fat mass of the Prolibra group was reduced 5.81 percent, and only 2.29 percent in the placebo group. In a second trial, 79 percent of the weight loss by the Prolibra group was fat, compared with 51 percent in the control. A third study showed a statistically significant reduction of postprandial glycemia.

"Glanbia Granted U.S. Patent for Prolibra Whey Ingredient", News release, Glanbia Nutritionals, September 09, 2010, © Penton Media Inc
Vitality & Better Living
North America
United States of America
Companies, Organizations
Legal, Legislation, Regulation, Policy
Market News
Press Release
Products & Brands
Research, Studies, Advice
Developed by Yuri Ingultsov Software Lab.